Call for papers - Reproduction, Technology and Society, a new section in Reproductive BioMedicine Online
Page URL:

Scientists map complete genome of cancer patient

10 November 2008
Appeared in BioNews 483

In a world first, scientists at Washington University, US, have sequenced the entire genome of a woman with acute myelogenous leukaemia (AML). They sequenced DNA from both normal skin cells and malignant tumour cells and found that 10 genes were mutated in the cancerous cells. The findings were published in the journal Nature.

The study found mutations in two genes that were previously known to be associated with AML. Eight of the mutations, however, have not been previously linked with the cancer. They also examined the DNA from tumour cells of 187 other AML patients, but found that none had any of the eight new mutations.

It is currently thought that a cell becomes cancerous after accumulating mutations throughout its life, each one pushing the cell towards uncontrolled malignant growth. Nine of the 10 mutations in this patient's case were found in all tumour cells, the tenth was only in some tumour cells, so it is possible that this mutation occurred last; the tipping point that caused the cancer.

Dr Richard Wilson, lead researcher of the study, said: 'We found mutations in genes that make a lot of sense when normal cells become cancer cells. That they seem to be fairly unique to this particular patient says on the one hand that this is a complicated disease'. He added that 'the complications validate our approach - we have to look at a number of patients to see not only what is different but what they have in common'. Further research is now underway to sequence the whole genome of another AML patient.

The technology for genome sequencing has become cheaper and more efficient since it was developed. When the first human genome sequence was completed in 2003, it had taken years and cost millions of pounds. Now, a human genome can be sequenced in months for a fraction of the cost. The researchers in Washington used a new technique called massively parallel sequencing. Although they sequenced the patient's entire genome, they only analysed mutations in the DNA sequences that produce proteins, an estimated 1 to 2 per cent of the human genome. To find mutations in other regions, known as intergenic DNA, will require further intensive analyses.

Understanding which mutations lead a cell to become cancerous can help scientists discover the underlying mechanisms of the disease, and open up avenues for discovering new treatments. In addition, understanding an individual's genetic basis of cancer could lead to highly personalised treatments.

Cancer genetic blueprint revealed
BBC News Online |  6 November 2008
First ever mapping of cancer patient's genome
Yahoo Daily News |  6 November 2008
Gene hunt finds cancer culprits
The Washington Post |  5 November 2008
Scientists map cancer patient's complete genome
Medical News Today |  6 November 2008
10 August 2009 - by Adam Fletcher 
The second complete cancer cell genome sequence was published online last week in the New England Journal of Medicine, representing a pioneering effort to comprehensively describe the hundreds of genetic changes that underlie this most insidious of diseases...
24 November 2008 - by Ailsa Stevens 
Scientists have for the first time sequenced the complete diploid genomes of an Asian and an African. It is hoped that the research, published in the journal Nature, will help to shed light on how people from different ethnic backgrounds respond to medicine and help to explain...
26 August 2008 - by Dr Rachael Panizzo 
As the price of genetic sequencing of an individual's DNA drops, personalized medical genomics will become increasingly integral to prescribing drugs and treating illnesses, leading genome researcher Craig Venter wrote in a commentary for the journal Clinical Pharmacology & Therapeutics. He predicts that genome-based healthcare will help to...
27 January 2008 - by Dr Jess Buxton 
An international project to read the entire genetic code of at least 1000 individuals will result in a comprehensive catalogue of human variation that will accelerate efforts to identify genetic factors involved in health and disease, scientists announced last week. The '1000 Genomes Project' will take...
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.